Ashford Capital Management »

Adma Biologics shares owned by Ashford Capital Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Ashford Capital Management from 13F filings

Historical chart of Ashford Capital Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Ashford Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Ashford Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 362k 9.01

More positions owned by Ashford Capital Management

Globalstar (GSAT)
Ligand Pharmaceuticals In (LGND)
Stonex Group (SNEX)
Supernus Pharmaceuticals (SUPN)
Vanguard Total Stock Market ETF (VTI)
Clear Secure (YOU)
Cellebrite Di Ltd Ordinary Shares (CLBT)
Red Violet (RDVT)
Equinix (EQIX)
Healthequity (HQY)
UFP Technologies (UFPT)
Franco-Nevada Corporation (FNV)
Vox Rty Corp Cda F (VOXR)
Vicor Corporation (VICR)
Acuity Brands (AYI)

View all positions for Ashford Capital Management

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Capital Research Global Investors
Vanguard Capital Management
Vanguard Portfolio Management
Citadel Advisors
Nuveen
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Invesco
Bank of America Corporation
Jane Street
Millennium Management

View all funds holding Adma Biologics